Novo CEO pressed by Senate to cut prices of obesity, diabetes medicine CEO Lars Fruergaard Jørgensen told lawmakers the corporate would think about new talks with insurers regarding the checklist charges of Wegovy and copyright should they pledge to maintain the medicines on their formularies. Insurers will carry on vertically https://daveshotchickennutrition51504.dbblog.net/3918015/facts-about-healthcare-news-revealed